After years of offshoring, commoditization and consolidation, investor interest is returning to North America’s technology-enabled dental laboratories as a new wave of M&A takes root, according to investment bankers and industry participants.

Dentists in the US and Canada are increasingly gravitating toward laboratory partners with advanced digital workflows and a commitment to domestic production as frustrations grow with offshore-heavy providers and the operational challenges of running in-house lab operations, said Jonathan Bluth, a managing director in Brown Gibbons Lang’s healthcare investment banking practice.

The shift is already evident in recent deal activity, including the majority recapitalization of Apex Dental Laboratory Group and a series of acquisitions by Caymus Equity-backed dental lab platform Catalis Dental Lab Partners.

Mergermarket data shows dealmaking involving North American dental labs and dental equipment manufacturers peaked at 18 transactions in 2021 before tapering off in subsequent years. Activity appears to be rebounding in 2026, however: eight deals have been announced so far, one short of the pace seen during the comparable period in 2021.

Source: Mergermarket, data correct as at 25-Jun-26

The first roll-up cycle

For decades, North America’s dental lab industry was dominated by highly skilled technicians operating local and regional businesses built on close relationships with dentists. That model began to shift as large national players scaled aggressively, centralized production and moved manufacturing offshore in pursuit of lower costs and greater scale, according to Bluth.

Three players – National Dentex Labs (NDX), Dental Services Group (DSG) and privately held Glidewell – long dominated the market. NDX and DSG drove the industry’s first major consolidation wave, rolling up regional labs into national platforms backed by multiple private equity sponsors. The trend culminated in 2021 when NDX acquired DSG, combining two of the sector’s largest consolidators. Glidewell remained founder-led and focused on digital dentistry and CAD/CAM technology, Bluth noted.

As platforms expanded and offshore production increased, many dentists experimented with chairside milling and in-office lab capabilities enabled by digital scanning and CAD/CAM technologies. While some practices embraced those systems, many found them expensive to operate, labor-intensive, and difficult to manage, Bluth said.

That has created an opening for a new generation of regional and mid-market labs, including Golden Ceramic Dental Lab (GCDL) and Dental Alliance Group, which have recently attracted acquisition interest, according to Dennis Marvel, owner of Dennis Marvel & Associates, a consulting and coaching firm focused on the dental industry.

While offshore production may offer lower upfront costs, dentists often underestimate the hidden tradeoffs, Marvel said.

“Offshore labs can destroy a practice’s reputation” when quality issues lead to remakes, adjustments and additional chair time that are not reflected in the per-unit price, he said.

Transparency is also a concern because many dentists do not know their lab partner is sending restorations offshore, Marvel added.

“Cheap isn’t always cheap,” he said.

At the same time, offshore production remains important, particularly for larger lab platforms serving dental service organizations (DSOs), according to Lance Bell, a managing director at Mesirow Investment Banking. More sophisticated operators have developed offshore capabilities to stay cost competitive and increase production capacity, often using multiple offshore vendors to navigate geopolitical risks, tariffs and trade restrictions, he said.

Nearshoring has also become more common, with operators utilizing production centers in markets such as Mexico and Costa Rica to reduce reliance on Asia, Bell noted.

Beyond the lab bench

In-house production creates a different set of challenges, Marvel said. While chairside milling gives dentists greater control over quality and turnaround times, it also requires capital investment, staff training and operational oversight.

Often dentists who attempt to bring everything in-house ultimately discover they are “running a manufacturing operation” rather than focusing on patient care and practice management, he added.

For many independent practice owners, regional and domestic labs that offer digital workflow integration have become the more attractive option, according to Marvel.

Advances in technology have strengthened the competitive position of domestic laboratories. Tools such as intraoral scanners and CAD/CAM systems reduce errors and accelerate turnaround times, changing what dentists expect from their lab partners, Marvel said.

Bell said digitalization is now a critical competitive advantage for regional operators. Compared to traditional analog impressions, digital workflows have shortened turnaround times and reduced rework, while customer portals and workflow-management tools have improved visibility and customer retention, he said.

Continued advances in technology have also helped narrow — and in some cases eliminate — the historical cost differential between offshore and domestic production, Bell added.

These investments are creating “competitive moats” for regional operators, making them more attractive acquisition targets, Bell said.

Apex Dental, recapitalized by LongueVue Capital and Swaney Group Capital in March 2026, is among the new breed of dental labs emphasizing domestic manufacturing capabilities. Another is Catalis Dental, previously known as Pan-Am Dental, which acquired Revolution Dental Lab, JB Dental Lab, and Avaneer Dental Studio, expanding its geographic footprint and digital capabilities and helping position it among the 10 largest US dental lab groups.

Other deals involving domestic operators include Standard Dental Labs’ 2025 Florida roll-up strategy, The Zabel Companies’ 2024 acquisition of GCDL, and Centerfield Capital Partners’ 2024 acquisition of Cap City Dental Lab, operating as Dental Alliance Group.

While offshore and nearshore manufacturing will remain part of the supply chain, technology-enabled regional labs are carving out a differentiated position in the market and emerging as some of the sector’s most attractive M&A targets, sources said.